Search
European Drug Report 2024: Trends and Developments
The European Drug Report 2024: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report provides a comprehensive set of...
DIMS Annual Report 2022
The DIMS annual report 2022 covers the concentrations, adulterations, and other relevant information produced by DIMS in the past year, and in doing so forms a topical image of the Dutch drug market. Spread out over all Dutch provinces, the...
How People Living in Canada Consume and Acquire Cannabis: Assessing Progress in Minimizing Harms and Establishing a Safe Supply Chain
Summary
People’s attitudes and behaviours about cannabis have shifted since it was legalized in 2018. The Canadian Centre on Substance Use and Addiction (CCSA) has funded research to examine these changes.
As we approach the three-year...
Risks and Harms Associated with the Nonmedical Use of Benzodiazepines in the Unregulated Drug Supply in Canada
Summary
Substance use risks are significantly higher for people who obtain drugs on the unregulated market as there is no quality control and drug contents are unpredictable. This lack of predictability has increased during the COVID-19...
Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member